Profile of ustekinumab and its potential in patients with moderate-to-severe Crohn’s disease

por Tuskey, Anne, Behm, Brian W
Publicado 2014

Chronic Cholestatic Liver Injury Attributable to Vedolizumab

por Stine, Jonathan G., Wang, Jennifer, Behm, Brian W.
Publicado en J Clin Transl Hepatol (2016)

Coil Migration after Transarterial Coil Embolization of a Splenic Artery Pseudoaneurysm

por Tekola, Bezawit D., Arner, David M., Behm, Brian W.
Publicado 2013

Polypharmacy is a risk factor for disease flare in adult patients with ulcerative colitis: a retrospective cohort study

por Wang, Jingzhou, Nakamura, Takahiro I, Tuskey, Anne G, Behm, Brian W
Publicado en Intest Res (2019)

Zinc Deficiency and the Recurrence of Clostridium difficile Infection after Fecal Microbiota Transplant: A Retrospective Cohort Study

por Niccum, Blake A., Stein, Daniel J., Behm, Brian W., Hays, R. Ann
Publicado en J Nutr Metab (2018)

Opioid use and misuse in ulcerative colitis

por Chitnavis, Maithili V, Baray, Merwise, Northup, Patrick G, Tuskey, Anne G, Behm, Brian W
Publicado en World J Gastrointest Pharmacol Ther (2019)

Treatment of Type-1 Hepatorenal Syndrome with Pentoxifylline: A Randomized Placebo Controlled Clinical Trial

por Stine, Jonathan G., Wang, Jennifer, Cornella, Scott L., Behm, Brian W., Henry, Zachary, Shah, Neeral L., Caldwell, Stephen H., Northup, Patrick G.
Publicado en Ann Hepatol (2018)